Spark Gets FDA Greenlight for Luxturna, The First Gene Therapy for Eye Disease Approved in the U.S. Post author:Sam Post published:December 18, 2017 Post category:BioPharma The FDA broke new ground today with a first-of-its-kind therapy for eye disease. Source: BioSpace You Might Also Like IFM Therapeutics Appoints Renowned Physicians From Academia And Industry To Clinical Advisory Board February 22, 2017 IRadimed Corporation Poised For Market Domination February 13, 2017 Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases October 2, 2017
IFM Therapeutics Appoints Renowned Physicians From Academia And Industry To Clinical Advisory Board February 22, 2017
Celgene Cuddles Up With Another Cambridge Biotech, This Time to Tackle Autoimmune Diseases October 2, 2017
